Correlation Between Naked Wines and Centessa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Naked Wines and Centessa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Naked Wines and Centessa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Naked Wines plc and Centessa Pharmaceuticals PLC, you can compare the effects of market volatilities on Naked Wines and Centessa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Naked Wines with a short position of Centessa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Naked Wines and Centessa Pharmaceuticals.
Diversification Opportunities for Naked Wines and Centessa Pharmaceuticals
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Naked and Centessa is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Naked Wines plc and Centessa Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Centessa Pharmaceuticals and Naked Wines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Naked Wines plc are associated (or correlated) with Centessa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Centessa Pharmaceuticals has no effect on the direction of Naked Wines i.e., Naked Wines and Centessa Pharmaceuticals go up and down completely randomly.
Pair Corralation between Naked Wines and Centessa Pharmaceuticals
Assuming the 90 days horizon Naked Wines plc is expected to under-perform the Centessa Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, Naked Wines plc is 2.9 times less risky than Centessa Pharmaceuticals. The pink sheet trades about -0.23 of its potential returns per unit of risk. The Centessa Pharmaceuticals PLC is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1,710 in Centessa Pharmaceuticals PLC on September 24, 2024 and sell it today you would earn a total of 6.00 from holding Centessa Pharmaceuticals PLC or generate 0.35% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Naked Wines plc vs. Centessa Pharmaceuticals PLC
Performance |
Timeline |
Naked Wines plc |
Centessa Pharmaceuticals |
Naked Wines and Centessa Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Naked Wines and Centessa Pharmaceuticals
The main advantage of trading using opposite Naked Wines and Centessa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Naked Wines position performs unexpectedly, Centessa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centessa Pharmaceuticals will offset losses from the drop in Centessa Pharmaceuticals' long position.Naked Wines vs. Aristocrat Group Corp | Naked Wines vs. Naked Wines plc | Naked Wines vs. Willamette Valley Vineyards | Naked Wines vs. Andrew Peller Limited |
Centessa Pharmaceuticals vs. Fate Therapeutics | Centessa Pharmaceuticals vs. Sana Biotechnology | Centessa Pharmaceuticals vs. Caribou Biosciences | Centessa Pharmaceuticals vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
CEOs Directory Screen CEOs from public companies around the world |